Delivery Order SPE2DB20D3103-SPE2DB25FP5C8

Award Date 7/15/25
Potential Completion Date 7/16/25
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of risperidone 0.25 mg tablets. The contract, valued at $1,514.21, is a firm fixed-price delivery order with an ultimate completion date of April 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Risperidone 0.25 mg tablets. The contract has a ceiling value of $1,509.03 and a period of performance through July 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,853.10 firm fixed price delivery order covers the supply of RISPERIDONE 0.25 MG TABLET 60S, with a period of performance through August 26, 2024. The contract is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 500 tablet bottles of the medication Risperidone 0.25 mg, with a ceiling value of $6,662.79 and a completion date of June 6, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,775.10, is for the delivery of 4,566,526,169 tablets of Risperidone 0.25 mg. It is a firm fixed-price delivery order contract with a completion date of November 25, 2024. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $2,508.01 firm fixed-price delivery order is for the supply of 500 tablets of 0.25 mg risperidone, a medication used to treat mental health conditions. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of RISPERIDONE 0.5 MG TABLET 60S. The contract has a firm fixed price and a ceiling value of $1,524.53. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,756.67, is for the delivery of 60 tablets of the prescription medication Risperidone 0.5 mg. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RISPERIDONE 0.5 MG TABLET 60S, with a ceiling value of $1,550.83 and a performance period through June 16, 2025. The contract is not set aside and was awarded on June 13, 2025. Amerisourcebergen Drug Corp is a for-profit organization headquartered in...
This federal contract award, valued at $1,537.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Risperidone 0.25 mg tablets, a pharmaceutical product, to support DLA facilities and the Department of Defense (DoD) worldwide. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FP5C8
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 500 tablets of risperidone 0.25 mg. The contract has a ceiling value of $6,411.02 and a performance period ending on July 16, 2025. This award is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to various federal agencies, particularly the DLA. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This specific delivery order is a small-volume purchase within the broader IDC, supporting military healthcare programs and other government agencies' medical supply needs.

Generated 10/14/25, 10:49 AM